期刊文献+

The clinical experience of pirfenidone based on corticosteroids and immunosuppressant treatment for interstitial pneumonia with autoimmune features

The clinical experience of pirfenidone based on corticosteroids and immunosuppressant treatment for interstitial pneumonia with autoimmune features
原文传递
导出
摘要 Objective To explore the effect of pirfenidone on fibrotic interstitial pneumonia with autoimmune features(IPAF)after treatment with corticosteroids and immunosuppressants.Methods We conducted a retrospective analysis of 2 adult patients with IPAF in Peking Union Medical College Hospital.As their fibrotic interstitial lung disease failed to improve with further treatment with corticosteroids and immunosuppressants,they were treated with pirfenidone based on corticosteroids and immunosuppressants.Their clinical,chest radiological data and prognosis were collected and relevant literatures were reviewed.Results One patient was a 43 year old female,the other was a 53 year old male.IPAF was diag nosed with their classic clinical,serological and radiological features.
作者 HUANG Hui 黄慧(Dept Respir Med,PUMC Hosp,Beijing 100730)
机构地区 Dept Respir Med
出处 《China Medical Abstracts(Internal Medicine)》 2019年第4期216-216,共1页 中国医学文摘(内科学分册(英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部